Charles Schwab’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $749K | Sell |
119,651
-18,815
| -14% | -$118K | ﹤0.01% | 2994 |
|
|
2025
Q1 | $811K | Hold |
138,466
| – | – | ﹤0.01% | 2913 |
|
|
2024
Q4 | $1.14M | Buy |
138,466
+110
| +0.1% | +$904 | ﹤0.01% | 2873 |
|
|
2024
Q3 | $1.23M | Buy |
138,356
+3,612
| +3% | +$32.2K | ﹤0.01% | 2857 |
|
|
2024
Q2 | $1.02M | Buy |
134,744
+28,500
| +27% | +$215K | ﹤0.01% | 2929 |
|
|
2024
Q1 | $834K | Buy |
106,244
+14,796
| +16% | +$116K | ﹤0.01% | 2849 |
|
|
2023
Q4 | $810K | Buy |
91,448
+18,725
| +26% | +$166K | ﹤0.01% | 2901 |
|
|
2023
Q3 | $652K | Hold |
72,723
| – | – | ﹤0.01% | 2946 |
|
|
2023
Q2 | $898K | Buy |
72,723
+9,310
| +15% | +$115K | ﹤0.01% | 2808 |
|
|
2023
Q1 | $588K | Buy |
63,413
+15,606
| +33% | +$145K | ﹤0.01% | 2897 |
|
|
2022
Q4 | $502K | Buy |
47,807
+804
| +2% | +$8.44K | ﹤0.01% | 3003 |
|
|
2022
Q3 | $852K | Buy |
47,003
+3,994
| +9% | +$72.4K | ﹤0.01% | 2835 |
|
|
2022
Q2 | $610K | Buy |
43,009
+27,630
| +180% | +$392K | ﹤0.01% | 2994 |
|
|
2022
Q1 | $339K | Buy |
15,379
+3,557
| +30% | +$78.4K | ﹤0.01% | 3187 |
|
|
2021
Q4 | $201K | Buy |
+11,822
| New | +$201K | ﹤0.01% | 3357 |
|